Patents by Inventor Kong T. Chong

Kong T. Chong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5837229
    Abstract: A colony stimulating factor, CSF-1, is a lymphokine useful in treating or preventing bacterial, viral or fungal infections, neoplasms, leukopenia, wounds, and in overcoming the immunosuppression induced by chemotherapy or resulting from other causes. CSF-1 is obtained in usable amounts by recombinant methods, including cloning and expression of the murine and human DNA sequences encoding this protein.
    Type: Grant
    Filed: January 11, 1995
    Date of Patent: November 17, 1998
    Assignee: Chiron Corporation
    Inventors: Peter Ralph, Kong T. Chong
  • Patent number: 5725850
    Abstract: A colony stimulating factor, CSF-1, is a lymphokine useful in treating or preventing bacterial, viral or fungal infections, neoplasms, leukopenia, wounds, and in overcoming the immunosuppression induced by chemotherapy or resulting from other causes. CSF-1 is obtained in usable amounts by recombinant methods, including cloning and expression of the murine and human DNA sequences encoding this protein.
    Type: Grant
    Filed: January 11, 1995
    Date of Patent: March 10, 1998
    Assignee: Chiron Corporation
    Inventors: Peter Ralph, Kong T. Chong, James Devlin, Robert Zimmerman, Sharon Lea Aukerman, David B. Ring, Sylvia Hsieh Ma
  • Patent number: 5635175
    Abstract: A colony stimulating factor, CSF-1, is a lymphokine useful in treating or preventing bacterial, viral or fungal infections, neoplasms, leukopenia, wounds, and in overcoming the immunosuppression induced by chemotherapy or resulting from other causes. CSF-1 is obtained in usable amounts by recombinant methods, including cloning and expression of the murine and human DNA sequences encoding this protein.
    Type: Grant
    Filed: January 11, 1995
    Date of Patent: June 3, 1997
    Assignee: Chiron Corporation
    Inventors: Peter Ralph, Kong T. Chong
  • Patent number: 5614183
    Abstract: A colony stimulating factor, CSF-1, is a lymphokine useful in treating or preventing bacterial, viral or fungal infections, neoplasms, leukopenia, wounds, and in overcoming the immunosuppression induced by chemotherapy or resulting from other causes. CSF-1 is obtained in usable amounts by recombinant methods, including cloning and expression of the murine and human DNA sequences encoding this protein.
    Type: Grant
    Filed: January 11, 1995
    Date of Patent: March 25, 1997
    Assignee: Chiron Corporation
    Inventors: Peter Ralph, Kong T. Chong
  • Patent number: 5422105
    Abstract: A colony stimulating factor, CSF-1, is a lymphokine useful in treating or preventing bacterial, vital or fungal infections, neoplasms, leukopenia, wounds, and in overcoming the immunosuppression induced by chemotherapy or resulting from other causes. CSF-1 is obtained in usable amounts by recombinant methods, including cloning and expression of the murine and human DNA sequences encoding this protein.
    Type: Grant
    Filed: March 1, 1994
    Date of Patent: June 6, 1995
    Assignee: Cetus Oncology Corporation
    Inventors: Peter Ralph, Kong T. Chong
  • Patent number: 5104650
    Abstract: A colony stimulating factor, CSF-1, is a lymphokine useful in overcoming the immunosuppression induced by chemotherapy or resulting from other causes. CSF-1 is obtained in usable amounts by recombinant methods, including cloning and expression of the murine and human DNA sequences encoding this protein.
    Type: Grant
    Filed: September 22, 1987
    Date of Patent: April 14, 1992
    Assignee: Cetus Corporation
    Inventors: Peter Ralph, Mary K. Warren, Kong T. Chong, James J. Devlin, Robert Zimmerman, Ada H. C. Kung